Menin-MLL inhibitor 20

CAS No. 2448173-47-3

Menin-MLL inhibitor 20( —— )

Catalog No. M28660 CAS No. 2448173-47-3

Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 87 In Stock
5MG 79 In Stock
10MG 130 In Stock
25MG 264 In Stock
50MG 382 In Stock
100MG 544 In Stock
200MG 737 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Menin-MLL inhibitor 20
  • Note
    Research use only, not for human use.
  • Brief Description
    Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
  • Description
    Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    γ-secretase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2448173-47-3
  • Formula Weight
    612.72
  • Molecular Formula
    C33H40N8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (54.40 mM)
  • SMILES
    CC(C)(C)OC(N[C@H]1CN(Cc2cc(C(Nc(cc3)ccc3-c([nH]3)cc4c3ncnc4N3CCOCC3)=O)ncc2)CCC1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao B, et al. Identification of gamma-secretase inhibitor potency determinants on presenilin. J Biol Chem. 2008 Feb 1;283(5):2927-38.
molnova catalog
related products
  • Trotabresib

    Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.

  • dBRD9 HCl

    dBRD9 HCl is a PROTAC composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide . dBRD9 HCl is a potent and selective degrader of BRD9 (IC50 = 56.6 nM in MOLM-13 cells).

  • CBP-IN-1

    CBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.